Impairment of neutrophil reactivity to elastin peptides in COPD

Thorax

Volumn 68, Issue 5, 2013, Pages 421-428

  Dupont, Aurélie ^a   Dury, Sandra ^a,b   Gafa, Valérie ^a   Lebargy, François ^a,b   Deslée, Gaëtan ^b,c   Guenounou, Moncef ^a   Antonicelli, Frank ^c   Le Naour, Richard ^a  

^a Université de Reims Champagne Ardenne ^*  (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ELASTIN; ELASTIN RECEPTOR; PEPTIDE; REACTIVE OXYGEN METABOLITE; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CELL DISRUPTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA;

EID: 84876282566     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201833     Document Type: Article

References (36)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2010. http://www.goldcopd.org (accessed Aug 2011).
2. Agustí AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-60. (Pubitemid 36204553)
3. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001;18 (Suppl 34):50s-9s. (Pubitemid 34760609)
4. Pinto-Plata VM, Livnat G, Girish M, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007;131:37-43. (Pubitemid 46122972)
5. Barnes PJ. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 2003;54:113-29. (Pubitemid 37386387)
6. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65.
7. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-80. (Pubitemid 30490396)
8. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928. (Pubitemid 38680444)
9. Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophils is mediated through activation of proteases by K1 flux. Nature 2002;416:291-7. (Pubitemid 34260237)
10. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-21. (Pubitemid 27227073)
11. Owen CA. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:373-85. (Pubitemid 41699700)
12. Lombard C, Arzel L, Bouchu D, et al. Human leukocyte elastase hydrolysis of peptides derived from human elastin exon 24. Biochimie 2006;88:1915-21. (Pubitemid 44895566)
13. Gottlieb DJ, Stone PJ, Sparrow D, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med 1996;154:1290-95. (Pubitemid 26391171)
14. Schriver EE, Davidson JM, Sutcliffe MC, et al. Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:762-6.
15. Betsuyaku T, Nishimura M, Yoshioka A, et al. Elastin-derived peptides and neutrophil elastase in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1996;154:720-4. (Pubitemid 26327297)
16. Senior RM, Griffin GL, Mecham RP. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 1982;70:614-18. (Pubitemid 12054586)
17. Senior RM, Griffin GL, Mecham RP, et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984;99:870-4. (Pubitemid 14043344)
18. Ghuysen-Itard AF, Robert L, Jacob MP. Effect of elastin peptides on cell proliferation. C R Acad Sci III 1992;315:473-8. (Pubitemid 23295849)
19. Faury G, Ristori MT, Verdetti J, et al. Effect of elastin peptides on vascular tone. J Vasc Res 1995;32:112-19.
20. Baranek T, Debret R, Antonicelli F, et al. Elastin receptor (spliced galactosidase) occupancy by elastin peptides counteracts pro-inflammatory cytokine expression in lipopolysaccharide-stimulated human monocytes through NF-kappaB down-regulation. J Immunol 2007;179:6184-92.
21. Debret R, Le Naour R, Sallenave JM, et al. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J Invest Dermatol 2006;126:1860-68. (Pubitemid 44086521)
22. Hinek A, Rabinovitch M, Keeley F, et al. The 67-kD elastin/laminin- binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest 1993;91:1198-205. (Pubitemid 23095299)
23. Duca L, Blanchevoye C, Cantarelli B, et al. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem 2007;282:12484-91. (Pubitemid 47100624)
24. Larbi A, Levesque G, Robert L, et al. Presence and active synthesis of the 67 kDa elastin-receptor in human circulating white blood cells. Biochem Biophys Res Comm 2005;332:787-92. (Pubitemid 40745182)
25. Mecham RP, Whitehouse L, Hay M, et al. Ligand affinity of the 67-kD elastin/laminin binding protein is modulated by the protein's lectin domain: visualization of elastin/laminin-receptor complexes with gold-tagged ligands. J Cell Biol 1991;113:187-94. (Pubitemid 21909685)
26. Smith ER, Tomlinson LA, Ford ML, et al. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 2012;59:973-8.
27. Debret R, Antonicelli F, Theill A, et al. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol 2005;25:1353-58. (Pubitemid 40923351)
28. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-9. (Pubitemid 46828488)
29. Nowak D, Główczyńska I, Piasecka G. Chemotactic activity of elastin-derived peptides for human polymorphonuclear leukocytes and their effect on hydrogen peroxide and myeloperoxidase release. Arch Immunol Ther Exp 1989;37:741-8.
30. Grosso LE, Scott M. PGAIPG, a repeated hexapeptide of bovine and human tropoelastin, is chemotactic for neutrophils and Lewis lung carcinoma cells. Arch Biochem Biophys 1993;305:401-4. (Pubitemid 23282923)
31. Kreisel D, Nava RG, Li W, et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 2010;107:18073-8.
32. Hurst JR, Wedzicha JA. The biology of a chronic obstructive pulmonary disease exacerbation. Clin Chest Med 2007;28:525-36. (Pubitemid 47284586)
33. Yoshikawa T, Dent G, Ward J, et al. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:473-9. (Pubitemid 46354251)
34. Milara J, Juan G, Peiró T, et al. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy. Respiration 2012;83:147-58.
35. Overbeek SA, Braber S, Henricks PA, et al. Cigarette smoke induces β2-integrin-dependent neutrophil migration across human endothelium. Respir Res 2011;8:75-86.
36. Hinek A, Keeley FW, Callahan J. Recycling of the 67-kDa elastin binding protein in arterial myocytes is imperative for secretion of tropoelastin. Exp Cell Res 1995;220:312-24.